Novel opportunities for CFTR-targeting drug development using organoids. - Wikidata - awgldk - TriplyDB

Novel opportunities for CFTR-targeting drug development using organoids.

Novel opportunities for CFTR-targeting drug development using organoids.

http://www.wikidata.org/entity/Q39496065

about

Long-Term Culture of Intestinal Cell Progenitors: An Overview of Their Development, Application, and Associated Technologies Concise Review: Organoids Are a Powerful Tool for the Study of Liver Disease and Personalized Treatment Design in Humans and Animals.Organoid biobanking: identifying the ethics: Organoids revive old and raise new ethical challenges for basic research and therapeutic use.Deep resequencing of CFTR in 762 F508del homozygotes reveals clusters of non-coding variants associated with cystic fibrosis disease traits.Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients.Gastroenterological endpoints in drug trials for cystic fibrosis.Finding new drugs to enhance anion secretion in cystic fibrosis: Toward suitable systems for better drug screening. Report on the pre-conference meeting to the 12th ECFS Basic Science Conference, Albufeira, 25-28 March 2015.rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.Individualized medicine using intestinal responses to CFTR potentiators and correctors.Nasospheroids permit measurements of CFTR-dependent fluid transport.Toward inclusive therapy with CFTR modulators: Progress and challenges.

P2860

Q28076085-745C3202-393E-4C54-BE16-90581E70BA3E Q36728550-0E48717A-98CE-4800-9835-FC158D879FAF Q37061717-A21003E8-6706-4284-8227-E3486E94F4E1 Q37433652-8DAC13BC-81C3-4F10-9E20-5D5DE9DB27B6 Q38746661-5F23247A-B5C1-4F39-AF76-D84BB14A1A7F Q38839321-50D9FFA5-F870-493E-B1FB-490061DA8797 Q38910094-6A6B6E6B-3298-4B2D-9772-657D10915764 Q38949076-CD2EAB60-9A8B-43BE-AC56-93D7BD2367FE Q38962735-F8714E1A-3F74-43F0-9D1B-23B1B4DD649A Q47657423-CD179E1C-C424-4FE8-833D-5911AA74A535 Q47842086-6C9D0BAD-BBE6-4654-8C95-ED93B663DD9E

P2860

Novel opportunities for CFTR-targeting drug development using organoids.

http://www.wikidata.org/entity/Q39496065

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Novel opportunities for CFTR-targeting drug development using organoids.

@en

Novel opportunities for CFTR-targeting drug development using organoids.

@nl

type

label

Novel opportunities for CFTR-targeting drug development using organoids.

@en

Novel opportunities for CFTR-targeting drug development using organoids.

@nl

prefLabel

Novel opportunities for CFTR-targeting drug development using organoids.

@en

Novel opportunities for CFTR-targeting drug development using organoids.

@nl

P1433

Q39496065-4AC20A18-0364-411F-9FCE-39DB7203B792

P1476

Q39496065-C6147AF5-BC05-425C-B8D0-14A2B527E16E

P2093

Q39496065-312BE99E-73AC-49C6-A345-A215E1BC2DA6

Q39496065-76021E23-4B36-4CF7-BEF0-B33E0AAF8731

Q39496065-D15E50C3-D78A-47D7-BD73-6B3157346625

P2860

Q39496065-06561FFA-85EE-427A-82A0-493052DE7C7E

Q39496065-0792ED9C-0C70-4340-83DD-466ED858F556

Q39496065-122BF29D-0B71-488B-808B-E667EE1E24F2

Q39496065-12BA1BA6-BD18-43FD-8037-DC8E47FDC177

Q39496065-21CA6E9B-0635-41B9-8D75-4C57CE2877CE

Q39496065-22B7BBB1-2842-4ADC-83DA-624E9DD30ED2

Q39496065-249CC22D-4BF0-4A9D-9FD4-BF5AB37586B0

Q39496065-26035726-C2F8-4253-9F1A-F5799A169350

Q39496065-2AAA3615-548B-419E-B5FB-A8C11625CAD5

Q39496065-2BFD0035-FA0B-4310-A7F3-190F63021D0E

P304

Q39496065-C31AC4F9-DC5A-4E3F-B3E3-E122A7E23EAA

P31

Q39496065-F28FAE64-0873-41AF-A8CC-A32BBF1CC853

P356

Q39496065-11275EB4-1A94-4180-8EC7-AD6F3EFFE136

P478

Q39496065-6711223F-DC78-4D9C-ABF9-7B4309062B72

P577

Q39496065-517BBB8C-A426-43DA-931A-5523FDD29269

P5875

Q39496065-45143FB3-D4CD-46F3-9D6E-784FF3946AE4

P698

Q39496065-71192D5E-D0CD-4A39-B904-A98407F85799

P932

Q39496065-90D21D27-53B6-4760-8317-411348DB5152

P356

P1433

Rare diseases (Austin, Tex.)

P1476

Novel opportunities for CFTR-targeting drug development using organoids.

@en

P2093

Cornelis K van der Ent

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Beekman

http://www.w3.org/2001/XMLSchema#string

Johanna F Dekkers

http://www.w3.org/2001/XMLSchema#string

P2860

Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche

Cystic fibrosis

A functional CFTR assay using primary cystic fibrosis intestinal organoids

Heritability of lung disease severity in cystic fibrosis.

Rectal forceps biopsy procedure in cystic fibrosis: technical aspects and patients perspective for clinical trials feasibility.

Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data.

Genotype and phenotype in cystic fibrosis.

The K+ channel opener 1-EBIO potentiates residual function of mutant CFTR in rectal biopsies from cystic fibrosis patients.

P304

e27112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/RDIS.27112

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263741751

http://www.w3.org/2001/XMLSchema#string

P698

25003014

http://www.w3.org/2001/XMLSchema#string

P932

3915567

http://www.w3.org/2001/XMLSchema#string